Innoviva is trading 10.25% down at $19.00, with no new company-specific announcement identified for August 26, 2026.
- Investor relations lists its latest release on August 11, concerning pharmaceutical award finalists.
- Second-quarter results were released August 5.
- The broader market is nearly flat; recent filings include ownership forms, but available results do not establish a specific negative catalyst.